4//SEC Filing
Howell Peyton R 4
Accession 0001438133-25-000105
CIK 0001438133other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:03 PM ET
Size
9.2 KB
Accession
0001438133-25-000105
Insider Transaction Report
Form 4
Howell Peyton R
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-22$20.64/sh+4,387$90,548→ 21,077 total - Exercise/Conversion
Restricted Stock Unit
2025-05-22−4,387→ 0 total→ Common Stock (4,387 underlying) - Award
Restricted Stock Unit
2025-05-21+8,759→ 8,759 total→ Common Stock (8,759 underlying)
Footnotes (4)
- [F1]Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F3]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- [F4]Awarded on May 21, 2025 pursuant to the 2023 Plan.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001528056
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:03 PM ET
- Size
- 9.2 KB